| |
Derivation set
|
Validation set
|
|---|
|
Systematic reviews, N (%)
|
10 (42%)
|
14 (58%)
|
|
Type of review, N (%)
|
|
Systematic review without meta-analysis
|
7 (70%)
|
7 (50%)
|
|
Systematic review with meta-analysis
|
2 (20%)
|
5 (36%)
|
|
Scoping review
|
1 (10%)
|
2 (14%)
|
|
Living review
|
0 (0%)
|
4 (29%)
|
|
Focus
|
|
Therapeutic
|
3 (30%)
|
8 (57%)
|
|
Diagnosis
|
3 (30%)
|
2 (14%)
|
|
Prognosis
|
1 (10%)
|
1 (7%)
|
|
Other
|
3 (30%)
|
3 (21%)
|
|
Screening, median (range)
|
|
Abstract screened
|
484 (257 - 2469)
|
745.5 (232–9648)
|
|
Full-text screened
|
110 (15 - 441)
|
150 (16–453)
|
|
Eligible citations
|
27 (9 - 68)
|
21 (2–159)
|
|
Reviewers
|
3 (2 - 6)
|
5 (2–13)
|
|
Kappa
|
0.47 (0.25 - 0.76)
|
0.56 (0.37–0.9)
|
|
Field of study, N (%)
|
|
Pediatrics
|
8 (80%)
|
9 (64%)
|
|
Respirology
|
2 (20%)
|
1 (7%)
|
|
Development
|
2 (20%)
|
0 (0%)
|
|
Public Health
|
1 (10%)
|
5 (36%)
|
|
Pathology
|
1 (10%)
|
3 (21%)
|
|
Emergency
|
1 (10%)
|
1 (7%)
|
|
Medical Education
|
1 (10%)
|
1 (7%)
|
|
Surgery
|
1 (10%)
|
1 (7%)
|
|
Neonatology
|
1 (10%)
|
0 (0%)
|
|
Nursing
|
1 (10%)
|
0 (0%)
|
|
Oncology
|
1 (10%)
|
0 (0%)
|
|
Psychiatry
|
1 (10%)
|
0 (0%)
|
|
Radiology
|
1 (10%)
|
0 (0%)
|
|
Cardiology
|
0 (0%)
|
1 (7%)
|
|
Critical care
|
0 (0%)
|
1 (7%)
|
- Type of review and field of study were not exclusive, as studies can cover multiple choices. Numbers add up to more than 100%
